publicis

While agencies push for more programmatic buying options, publishers want to maintain control in TV ad buying negotiations – and particularly over their “premium” content.

Cookie loss is happening, even if it doesn’t feel imminent, and there’s no point in procrastinating, according to Sisi Zhang, chief data and analytics officer at Publicis-owned Razorfish.

In today’s newsletter: Big Tech may be best positioned to take advantage of generative AI’s ad tech uses; ad tech leaders waffle on investing in Chrome’s Privacy Sandbox; Google faces an innovator’s dilemma.

In today’s newsletter: Ad tech data can compromise Americans; Reddit has a hard road ahead revenue wise; CTV ad-buying startup tvScientific raises a funding round.

AdExchanger consulted with agencies about how they are evaluating new generative AI tools for marketing use cases as well as the tech companies behind these startups breaking new ground in generative AI.

The results of Haleon’s recent test of Adelaide’s attention scoring solution within Amazon’s DSP could strengthen the case that low-attention inventory isn’t worth buying.

“Standard advertising services” shouldn’t include recording intimate patient-doctor conversations to help drug companies guide doctors on how to push opioids.

In today’s newsletter: The FTC is suing Kochava (again); marketers are complacent about third-party cookie deprecation; and Publicis Health pays the piper for its role in the opioid epidemic.

DEI is increasingly coming under scrutiny from activists and politicians. But some minority-owned and -targeted media and advertising businesses are thriving despite the increasingly fraught atmosphere around DEI initiatives.

Here’s today’s AdExchanger.com news round-up… Want it by email? Sign up here. What’s In Store? Netflix’s latest effort to push ads onto subscribers is – you guessed it – a retail bundle. The company is piloting a new package deal with French retailer Carrefour, Bloomberg reports. Customers in the French cities of Bordeaux and Rouen […]